Secondary Progressive Multiple Sclerosis: Patient Impact and Coverage Implications for New Therapies - Episode 10
A Labeling Indication of SPMS Can Treat More Patients
Fred Lublin, MD, says a new labeling indication of Secondary Progressive Multiple Sclerosis broadens whom you can treat. He adds this will be very helpful to patients because it will treat groups that are progressing slowly without agents of activity.
